ALERT:

Atrial Fibrillation Clinical Trial 20213171

[LCID Study Number: 20213171]

Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS Registry)

The purpose of this study is to, in a cohort of patients electively treated for atrial arrhythmia with IV sotalol (initiation or dose escalation), describe patient characteristics, short-term safety and efficacy, electrocardiographic monitoring, and PK and PD parameters (in a subset) associated with IV dosing approach.

Disease/Condition: Atrial Fibrillation

Department: Cardiology – Anticoagulation

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-1901

Protocol #: 20213171
Principal Investigator(s): Jonathan S. Silver
Study Coordinator(s): Jean Byrne
Trial Phase: Sponsor Initiated Study Observational